DE LUCA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.400
EU - Europa 10.309
AS - Asia 9.703
SA - Sud America 1.226
Continente sconosciuto - Info sul continente non disponibili 361
AF - Africa 173
OC - Oceania 71
Totale 41.243
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.105
GB - Regno Unito 4.080
SG - Singapore 2.785
CN - Cina 2.688
IT - Italia 2.253
HK - Hong Kong 1.366
BR - Brasile 952
SE - Svezia 857
VN - Vietnam 837
DE - Germania 629
FI - Finlandia 480
UA - Ucraina 456
BD - Bangladesh 407
TR - Turchia 366
FR - Francia 356
RU - Federazione Russa 319
KR - Corea 311
IN - India 196
CA - Canada 172
BG - Bulgaria 168
SI - Slovenia 166
JP - Giappone 136
NL - Olanda 128
ID - Indonesia 127
AR - Argentina 87
PL - Polonia 73
MX - Messico 70
IQ - Iraq 65
ZA - Sudafrica 62
AE - Emirati Arabi Uniti 52
ES - Italia 51
IE - Irlanda 49
PK - Pakistan 49
EC - Ecuador 45
BE - Belgio 40
CO - Colombia 39
IR - Iran 39
CL - Cile 38
AU - Australia 37
AT - Austria 36
NZ - Nuova Zelanda 34
UZ - Uzbekistan 33
PH - Filippine 30
SA - Arabia Saudita 30
TW - Taiwan 30
CZ - Repubblica Ceca 27
LT - Lituania 27
MA - Marocco 26
MY - Malesia 25
VE - Venezuela 24
EG - Egitto 22
DK - Danimarca 20
RO - Romania 20
TH - Thailandia 17
DZ - Algeria 16
JO - Giordania 14
QA - Qatar 14
KE - Kenya 13
TN - Tunisia 13
CH - Svizzera 12
PT - Portogallo 12
PY - Paraguay 12
UY - Uruguay 12
IL - Israele 11
KZ - Kazakistan 11
NP - Nepal 11
PE - Perù 11
CR - Costa Rica 9
EU - Europa 9
AZ - Azerbaigian 8
AL - Albania 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
BY - Bielorussia 6
ET - Etiopia 6
HU - Ungheria 6
KW - Kuwait 6
NI - Nicaragua 6
PS - Palestinian Territory 6
RS - Serbia 6
MD - Moldavia 5
OM - Oman 5
SV - El Salvador 5
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
CG - Congo 3
KH - Cambogia 3
LB - Libano 3
LV - Lettonia 3
MN - Mongolia 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
BS - Bahamas 2
Totale 40.860
Salva come PNG Salva come JPEG
Città #
Southend 3.199
Santa Clara 1.862
Ashburn 1.734
Singapore 1.617
Fairfield 1.552
Hong Kong 1.339
Woodbridge 1.321
Chandler 1.029
Houston 1.000
Jacksonville 962
San Jose 856
Hefei 772
Dearborn 695
Ann Arbor 620
Wilmington 577
Cambridge 561
Seattle 552
Beijing 487
London 438
Nyköping 385
Los Angeles 346
Helsinki 309
The Dalles 279
Council Bluffs 275
Seoul 253
Ho Chi Minh City 250
Hanoi 215
Milan 214
Modena 213
New York 188
Chicago 183
San Diego 183
Izmir 180
Princeton 180
Sofia 166
Eugene 151
Lauterbourg 140
Rome 138
Des Moines 125
Buffalo 118
Bologna 107
Columbus 103
Bari 101
Moscow 96
Shanghai 90
Jakarta 86
São Paulo 83
Redwood City 82
Falls Church 81
Munich 80
Dallas 70
Salt Lake City 70
Tokyo 66
Boardman 56
Orem 50
Phoenix 49
Frankfurt am Main 46
Norwalk 46
Warsaw 40
Bremen 39
Dublin 38
Guangzhou 37
Haiphong 36
Toronto 35
Brooklyn 33
Atlanta 32
Kent 32
Tampa 32
Elk Grove Village 30
Brasília 29
Auckland 28
Changsha 28
Da Nang 28
Montreal 28
Xi'an 28
Belo Horizonte 27
Brussels 27
Chennai 27
Nanjing 27
Rio de Janeiro 27
Tashkent 27
Formigine 26
Paris 26
Baghdad 25
Denver 25
Miano 25
Reggio Emilia 25
Amsterdam 24
Falkenstein 24
Glasgow 24
Mexico City 24
Naples 24
Johannesburg 23
Campinas 22
Catania 22
Dhaka 22
Turin 22
Kunming 21
Medesano 21
Turku 21
Totale 28.187
Salva come PNG Salva come JPEG
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 892
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 588
Holoclar: first of its kind in more ways than one 535
Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro 481
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 433
Comparative assessment of cultures from oral and urethral stem cells for urethral regeneration 426
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides 420
Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine 392
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 387
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 383
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 379
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 375
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 369
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 361
Advances in Gene/Cell Therapy in Epidermolysis Bullosa 358
Polarized expression of integrin receptors (a6b4, a2b1, a3b1, avb5) and their relationshipwith the cytoskeleton and basement membrane matrix in cultured human keratinocytes. [5YIF: 10.77; Citations: 127] 354
A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording 350
Advances in stem cell research and therapeutic development 350
Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes 345
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 337
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 328
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 327
"HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis 324
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union 313
Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells 312
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. [5YIF: 3.60, Citations: 215] 307
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 305
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 305
The long and winding road that leads to a cure for epidermolysis bullosa 305
Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. 304
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 300
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 300
A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status 299
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 298
Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. 297
Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography 297
Chloride transport pathways in human keratinocytes 295
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 294
Gene therapy approaches for epidermolysis bullosa 294
Clonal analysis of human clonogenic keratinocytes 292
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 287
Corrective transduction of human epidermal stem cells in laminin-5-dependent Junctional Epidermolysis Bullosa. 286
Stem cell plasticity: time for a reappraisal? 285
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 285
A discussion on cell therapy in Manchester 279
Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors 278
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 277
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia 276
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies 274
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors 273
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls 273
p63 identifies keratinocyte stem cells 269
Corneal Bioengineering 267
Cell biology: Dormant and restless skin stem cells 265
Eyes on the prize: Limbal stem cells and corneal restoration 261
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1 261
Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. 261
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis 260
Characterization of chloride transport pathways in cultured human keratinocytes 259
Gene therapy of inherited skin adhesion disorders: a critical overview 257
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation 256
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 255
Treatment of 'stable' vitiligo by Timedsurgery transplantation of cultured epidermal autografts 255
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors 252
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing 250
Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes 250
Topography and biological role of integrins in human skin 250
Limbal stem-cell therapy and long-term corneal regeneration. 248
Towards a gene therapy clinical trial for epidermolysis bullosa 245
Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results 245
The importance of epidermal stem cells in keratinocyte-mediated gene therapy 242
Stamina therapies: Let the record stand 241
Regeneration of squamous epithelia from stem cells of cultured grafts 239
High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture 238
The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. 237
Advances on potential therapeutic options for epidermolysis bullosa 237
Ocular Albinism: evidence for a defect in an intracellular signal transduction system. 235
Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. 235
[Inhibition of the biosynthesis of thyroglobulin with propranolol in the rat] 235
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes 235
Towards therapeutic application of ocular stem cells 230
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes 228
Structural and functional studies of integrin receptors in cultured human keratinocytes 228
Clonal analysis of stably transduced human epidermal stem cells in culture. 228
Stairways to Advanced Therapies for Epidermolysis Bullosa 227
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study 226
Isoforms of ΔNp63 and the migration of ocular limbal cells in human corneal regeneration 226
CRYOPROTECTIVE AQUEOUS SOLUTIONS USEFUL FOR THE PRESERVATION OF IN VlTRO CULTURED EPITHELIAL SHEETS 220
Cultivation of human keratinocyte stem cells: current and future clinical applications 220
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid] 220
Toward gene therapy of junctional epidermolysis bullosa (JEB) 219
Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. 219
Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children 217
Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. 217
sAPP as a regulator of dendritic motility and melanin release in epidermal melanocytes and melanoma cells. 216
Biochemical role of FOXM1-dependent histone linker H1B in human epidermal stem cells 213
Culture of human epithelium 212
Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes 211
A multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium fresh or preserved in a frozen state 211
Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. 210
Totale 29.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.170 79 403 238 284 141 250 202 173 345 218 471 366
2022/20233.174 369 339 333 233 365 475 69 285 424 43 140 99
2023/20242.028 76 128 123 159 387 128 119 271 55 225 83 274
2024/20257.304 254 98 175 478 1.276 1.146 570 379 683 271 913 1.061
2025/202611.743 759 658 983 1.073 1.231 941 1.540 624 1.182 1.183 762 807
2026/2027398 398 0 0 0 0 0 0 0 0 0 0 0
Totale 41.243